Suppr超能文献

提高皮肤科医疗费用的可承受性:马克·库班成本加成制药公司与GoodRx的成本节约情况

Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx.

作者信息

Youn Christopher G, Kim Joo Yeon, Yang Vivian B, Bae Gordon H

机构信息

Department of Dermatology, Stanford University School of Dermatology, 450 Broadway, Pavilion C, 2nd Floor, Redwood City, CA, 94063, United States, 1 650-721-7190.

School of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, United States.

出版信息

JMIR Dermatol. 2024 Dec 13;7:e64300. doi: 10.2196/64300.

Abstract

This observational cost analysis was conducted to assess the efficacy of the Mark Cuban Cost Plus Drug Company (CostPlus) relative to GoodRx and found that CostPlus has significant potential to improve the financial burden of prescription medications within dermatology.

摘要

这项观察性成本分析旨在评估马克·库班成本加成制药公司(CostPlus)相对于GoodRx的疗效,发现CostPlus在减轻皮肤科处方药的经济负担方面具有巨大潜力。

相似文献

4
Drug Pricing Stewardship from Mark Cuban's Cost Plus Generic Drug Program.从马克·库班的成本加成仿制药计划看药品定价管理
Pharmacoeconomics. 2024 Nov;42(11):1279-1286. doi: 10.1007/s40273-024-01426-3. Epub 2024 Aug 21.
5
A cost analysis of medications prescribed by vascular surgeons.血管外科医生所开药物的成本分析。
J Vasc Surg. 2025 Jan;81(1):235-242. doi: 10.1016/j.jvs.2024.08.022. Epub 2024 Aug 22.
6
Comparing prescription drug saving platforms for dermatology: A cost analysis of Mark Cuban Cost Plus Drugs, GoodRx, and Amazon RxPass.
J Am Acad Dermatol. 2025 May;92(5):1138-1141. doi: 10.1016/j.jaad.2025.01.045. Epub 2025 Jan 23.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验